FERRARI, Silvia Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.613
EU - Europa 3.254
AS - Asia 3.095
SA - Sud America 386
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 16.421
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.482
GB - Regno Unito 1.578
SG - Singapore 906
CN - Cina 846
HK - Hong Kong 420
BR - Brasile 301
IT - Italia 297
SE - Svezia 262
FI - Finlandia 250
DE - Germania 246
VN - Vietnam 245
BD - Bangladesh 198
UA - Ucraina 188
TR - Turchia 175
FR - Francia 142
RU - Federazione Russa 122
CA - Canada 69
BG - Bulgaria 65
KR - Corea 49
ID - Indonesia 41
IN - India 39
AE - Emirati Arabi Uniti 34
AR - Argentina 31
ZA - Sudafrica 29
MX - Messico 27
NL - Olanda 23
PK - Pakistan 21
EC - Ecuador 20
JP - Giappone 20
IQ - Iraq 17
ES - Italia 15
PL - Polonia 15
IE - Irlanda 11
NP - Nepal 11
CL - Cile 10
CO - Colombia 10
BZ - Belize 9
MY - Malesia 9
VE - Venezuela 9
EG - Egitto 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
HN - Honduras 6
JO - Giordania 6
KE - Kenya 6
PH - Filippine 6
TH - Thailandia 6
BY - Bielorussia 5
JM - Giamaica 5
MA - Marocco 5
RO - Romania 5
AU - Australia 4
BE - Belgio 4
CH - Svizzera 4
HU - Ungheria 4
LT - Lituania 4
TW - Taiwan 4
AZ - Azerbaigian 3
ET - Etiopia 3
EU - Europa 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
SN - Senegal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BB - Barbados 2
BS - Bahamas 2
DK - Danimarca 2
DZ - Algeria 2
GT - Guatemala 2
IR - Iran 2
KG - Kirghizistan 2
MN - Mongolia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
IS - Islanda 1
LU - Lussemburgo 1
MD - Moldavia 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
Totale 16.417
Salva come PNG Salva come JPEG
Città #
Southend 1.275
Fairfield 911
Santa Clara 815
Ashburn 768
Woodbridge 589
Singapore 577
Chicago 480
Hong Kong 415
Jacksonville 389
Houston 353
Seattle 334
Los Angeles 321
Chandler 296
Cambridge 282
Wilmington 279
Dearborn 225
San Jose 218
Ann Arbor 217
Salt Lake City 205
Hefei 194
Helsinki 190
Nyköping 184
Beijing 173
London 167
Council Bluffs 157
Izmir 113
Tampa 94
New York 93
Elk Grove Village 92
Ho Chi Minh City 80
The Dalles 75
Princeton 70
San Diego 65
Sofia 64
Bremen 62
Modena 61
Eugene 58
Hanoi 57
Dallas 56
Lauterbourg 53
Sterling 50
Seoul 48
Buffalo 47
Lancaster 44
Milan 38
Frankfurt am Main 37
São Paulo 34
Shanghai 33
Moscow 32
Miami 31
Dulles 29
Columbus 28
Jakarta 28
Atlanta 26
Detroit 26
Des Moines 25
Toronto 21
Reading 20
Phoenix 18
Redwood City 17
Da Nang 16
Kansas City 15
Tokyo 15
Brooklyn 14
Dong Ket 14
Rome 14
Warsaw 14
Kunming 13
Mexico City 13
Boardman 12
Guangzhou 12
Haiphong 12
Montreal 12
Norwalk 12
Orem 12
Chiswick 11
Curitiba 11
Dublin 11
Pittsburgh 11
Denver 10
Hangzhou 10
Hounslow 10
Jersey City 10
Belize City 9
Kilburn 9
Turin 9
Charlotte 8
Johannesburg 8
Lahore 8
San Francisco 8
Baghdad 7
Belo Horizonte 7
Delhi 7
Miano 7
Philadelphia 7
Redondo Beach 7
Tashkent 7
Waterloo 7
Cairo 6
Chengdu 6
Totale 12.150
Salva come PNG Salva come JPEG
Nome #
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 763
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 438
Endocrine manifestations of hepatitis C virus infection. 388
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 376
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 369
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 369
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 360
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 358
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 341
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 340
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 339
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 334
Cytokines and HCV-related disorders 333
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 331
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 328
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 327
Associations between Systemic Sclerosis and Thyroid Diseases 324
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 316
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 307
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 294
CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis 293
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 292
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 287
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 284
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 281
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 276
New targeted molecular therapies for dedifferentiated thyroid cancer 271
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 270
[CXCR3 and CXCL10 in autoimmune thyroiditis] 265
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 264
IP-10 in autoimmune thyroiditis 260
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 258
Novel Therapies for Thyroid Autoimmune Diseases 255
HEPATITIS C IS ASSOCIATED WITH HIGH LEVELS OF CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND INTERLEUKIN-6 251
RET TKI: potential role in thyroid cancers. 243
[Cryoglobulinemia and the α-chemokine IP-10] 240
The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. 238
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists. 235
CXCL10 in psoriasis 230
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 229
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 223
High Levels of Circulating Chemokine (C-X-C motif) Ligand 11 Are Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis and with Chemokine (C-X-C Motif) Ligand 10 221
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 221
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 219
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 216
Interleukin-1beta, C-X-C Motif Ligand 10, and Interferon-Gamma Serum Levels in Mixed Cryoglobulinemia With or Without Autoimmune Thyroiditis. 206
α-Chemokine CXCL10 and β-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis 199
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 196
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 193
Extrahepatic manifestations of hepatitis C virus: the thyroid disorders 191
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine 185
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia 180
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 175
Role of CXCL10 in cryoglobulinemia 174
High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia 167
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 164
HCV-related autoimmune disorders in HCV chronic infection. 158
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 158
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 158
Mixed cryoglobulinemia and thyroid autoimmune disorders 133
Hepatitis C virus infection and type 2 diabetes. 123
Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience 120
Totale 16.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.135 53 154 194 68 8 55 72 41 96 90 190 114
2022/2023980 153 76 81 74 151 139 19 103 110 7 45 22
2023/2024640 12 37 38 120 158 25 45 62 12 37 31 63
2024/20252.262 64 13 19 188 529 376 73 124 286 205 188 197
2025/20265.738 177 144 295 958 1.690 330 466 188 439 345 386 320
2026/2027137 137 0 0 0 0 0 0 0 0 0 0 0
Totale 16.537